Morgan Stanley 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 10:09 am Sale | 2024-12-31 | 13G | UroGen Pharma Ltd. URGN | MORGAN STANLEY MS | 752,861 1.800% | -1,419,466 (-65.34%) | Filing |
| 2024-11-06 1:50 pm Purchase | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | MORGAN STANLEY MS | 2,172,327 5.200% | 2,172,327 (New Position) | Filing |